Lilliana Ramirez Garcia, MD
Dermatology · San Juan, PRNPI 1982937918
Payments from drug & device makers
Across 20 payments — averaging $66.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$469
- AbbVie$355
- Johnson & Johnson$261
- Sanofi$118
- Eli Lilly Export S.A. Puerto Rico Branch$75
- Revance Therapeutics, Inc.$29
- plus $32 from 2 others
What the payments were for
- Speaking & faculty fees$45034%
- Food & beverage$61246%
- Education$27621%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 2 | $469 |
| AbbVie(2 entities) | 7 | $355 |
| Johnson & Johnson | 3 | $261 |
| Sanofi | 2 | $118 |
| Eli Lilly Export S.A. Puerto Rico Branch | 3 | $75 |
| Revance Therapeutics, Inc. | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Pfizer | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$102
How this compares
$1,339 in reported general payments places this provider in the 40th percentile of 108 dermatology providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Sensoready (2 Pens)Secukinumab | 14 | $103,725 |
| Humira(Cf) PenAdalimumab | 12 | $83,995 |
| Dupixent PenDupilumab | 13 | $49,719 |
| Ketoconazole | 372 | $9,681 |
| Tacrolimus | 95 | $7,901 |
| Betamethasone Dipropionate | 141 | $6,134 |
| Ciclopirox | 173 | $5,938 |
| Desonide | 152 | $5,823 |
| Fluorouracil | 62 | $5,195 |
| Clobetasol Propionate | 52 | $3,742 |
| Fluocinolone AcetonideFluocinolone/Shower Cap | 42 | $3,319 |
| Metronidazole | 56 | $3,083 |
| Betamethasone Valerate | 49 | $2,099 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 42 | $2,032 |
| Clindamycin Phosphate | 44 | $1,858 |
Paid to pharmacies, not to this prescriber.
Other dermatology in San Juan
- Jose Gonzalez ChavezSan Juan$4.7M
- Maria Martinez ColonSan Juan$1.4M
- Rafael Martin GarciaSan Juan$199K
- Noelani Gonzalez-OrtizSan Juan$154K
- Elena Montalvan MiroSan Juan$20K
- Damaris Torres PaoliSan Juan$6K
- Natalia Pelet del ToroSan Juan$5K
- Frances HernandezSan Juan$5K
- Karina Cancel ArtauSan Juan$4K
- Eduardo Michelen GomezSan Juan$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.